within the rapidly evolving area of oncology study, exact and effective mutation screening is important for developing focused therapies. The KRAS products and services Platform plays a pivotal purpose in this landscape by presenting complete remedies for KRAS mutation profiling and Investigation. KRAS mutations, located in approximately 95% of RAS